Literature DB >> 26122615

p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Flore Kruiswijk1, Christiaan F Labuschagne1, Karen H Vousden2.   

Abstract

The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122615     DOI: 10.1038/nrm4007

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  172 in total

1.  p53 regulates mitochondrial respiration.

Authors:  Satoaki Matoba; Ju-Gyeong Kang; Willmar D Patino; Andrew Wragg; Manfred Boehm; Oksana Gavrilova; Paula J Hurley; Fred Bunz; Paul M Hwang
Journal:  Science       Date:  2006-05-25       Impact factor: 47.728

2.  The guardian recruits cops: the p53-p21 axis delegates prosurvival duties to the Keap1-Nrf2 stress pathway.

Authors:  Michel B Toledano
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

3.  Supercompetitor status of Drosophila Myc cells requires p53 as a fitness sensor to reprogram metabolism and promote viability.

Authors:  Claire de la Cova; Nanami Senoo-Matsuda; Marcello Ziosi; D Christine Wu; Paola Bellosta; Catarina M Quinzii; Laura A Johnston
Journal:  Cell Metab       Date:  2014-02-20       Impact factor: 27.287

4.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

5.  p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2.

Authors:  Tanupriya Contractor; Chris R Harris
Journal:  Cancer Res       Date:  2011-11-28       Impact factor: 12.701

Review 6.  Centrosomes, chromosome instability (CIN) and aneuploidy.

Authors:  Benjamin D Vitre; Don W Cleveland
Journal:  Curr Opin Cell Biol       Date:  2012-11-03       Impact factor: 8.382

Review 7.  Metabolic regulation by p53.

Authors:  Oliver D K Maddocks; Karen H Vousden
Journal:  J Mol Med (Berl)       Date:  2011-02-23       Impact factor: 4.599

8.  Selective activation of p53-mediated tumour suppression in high-grade tumours.

Authors:  Melissa R Junttila; Anthony N Karnezis; Daniel Garcia; Francesc Madriles; Roderik M Kortlever; Fanya Rostker; Lamorna Brown Swigart; David M Pham; Youngho Seo; Gerard I Evan; Carla P Martins
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

9.  Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53.

Authors:  Jaclyn S Long; Diane Crighton; James O'Prey; Gillian Mackay; Liang Zheng; Timothy M Palmer; Eyal Gottlieb; Kevin M Ryan
Journal:  Mol Cell       Date:  2013-04-18       Impact factor: 17.970

10.  Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence.

Authors:  Peng Jiang; Wenjing Du; Anthony Mancuso; Kathryn E Wellen; Xiaolu Yang
Journal:  Nature       Date:  2013-01-13       Impact factor: 49.962

View more
  412 in total

1.  p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.

Authors:  Natalia Artigas; Beatriz Gámez; Mónica Cubillos-Rojas; Cristina Sánchez-de Diego; José Antonio Valer; Gabriel Pons; José Luis Rosa; Francesc Ventura
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

2.  Lower MGMT expression predicts better prognosis in proneural-like glioblastoma.

Authors:  Zhi-Cheng He; Yi-Fang Ping; Sen-Lin Xu; Yong Lin; Shi-Cang Yu; Hsiang-Fu Kung; Xiu-Wu Bian
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 3.  Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Authors:  Michelle M Kim; Abhijit Parolia; Mark P Dunphy; Sriram Venneti
Journal:  Nat Rev Clin Oncol       Date:  2016-07-19       Impact factor: 66.675

4.  Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune System.

Authors:  Stefano Santaguida; Amelia Richardson; Divya Ramalingam Iyer; Ons M'Saad; Lauren Zasadil; Kristin A Knouse; Yao Liang Wong; Nicholas Rhind; Arshad Desai; Angelika Amon
Journal:  Dev Cell       Date:  2017-06-19       Impact factor: 12.270

5.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

Review 6.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 8.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.

Authors:  Gamze Kuser-Abali; Lu Gong; Jiawei Yan; Qingqing Liu; Weiqi Zeng; Amanda Williamson; Chuan Bian Lim; Mary Ellen Molloy; John B Little; Lei Huang; Zhi-Min Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-14       Impact factor: 11.205

10.  Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.

Authors:  Ziyi Wang; Kai Yang; Qiuyu Zheng; Chenting Zhang; Haiyang Tang; Aleksandra Babicheva; Qian Jiang; Meichan Li; Yuqin Chen; Shane G Carr; Kang Wu; Qian Zhang; Angela Balistrieri; Christina Wang; Shanshan Song; Ramon J Ayon; Ankit A Desai; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Wenju Lu; Jian Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.